Safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of subcutaneous and intravenous ALXN1720 in healthy volunteers: a phase 1, randomized, double-blind, placebocontrolled, single and multiple ascending dose study

被引：2
|
作者：
Ortiz, Stephan [1 ]
McEneny, Alanna [1 ]
Amancha, Praveen [1 ]
Rice, Kara [1 ]
Scholz, Joachim [1 ]
Rakhade, Sanjay [1 ]
Yee, Min [1 ]
机构：
[1] Alexion, AstraZeneca Rare Dis, Boston, MA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203482
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1-5.016
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers
    Jansen, Mendel
    Warrington, Steven
    Dishy, Victor
    Ohwada, Shoichi
    Johnson, Lisa
    Brown, Karen
    Ishizuka, Hitoshi
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (06): : 661 - 669
  • [22] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Zhao, Qian
    Liu, Hongzhong
    Wang, Zhenlei
    Wang, Teng
    Cui, Cheng
    Wang, Huanhuan
    Li, Lili
    Zhong, Wen
    Jiang, Ji
    Dong, Kai
    Chen, Shuai
    Jin, Chunyan
    Hu, Pei
    ADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198
  • [23] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Qian Zhao
    Hongzhong Liu
    Zhenlei Wang
    Teng Wang
    Cheng Cui
    Huanhuan Wang
    Lili Li
    Wen Zhong
    Ji Jiang
    Kai Dong
    Shuai Chen
    Chunyan Jin
    Pei Hu
    Advances in Therapy, 2023, 40 : 3186 - 3198
  • [24] A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects
    Hussaini, Azra
    Mukherjee, Rajat
    Berdieva, Dina M.
    Glogowski, Christen
    Mountfield, Richard
    Ho, Peter T. C.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (02): : 337 - 344
  • [25] Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers
    Barbour, April M.
    Sarov-Blat, Lea
    Cai, Gengqian
    Fossler, Michael J.
    Sprecher, Dennis L.
    Graggaber, Johann
    McGeoch, Adam T.
    Maison, Jo
    Cheriyan, Joseph
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (01) : 99 - 106
  • [26] A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AMG145
    Dias, Clapton
    Shaywitz, Adam
    Smith, Brian
    Emery, Maurice
    Bing, Gao
    Gibbs, John
    Wishner, Bill
    Stolman, Dina
    Crispino, Caroline
    Crispino, Caroline
    Cook, Blaire
    Colbert, Alex
    Retter, Marc
    Xu, Ren
    Matson, Mark
    CIRCULATION, 2011, 124 (21)
  • [27] Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase-1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study
    Wang, Yuhao
    Yu, Chao
    Hu, Mengyue
    Wang, Lu
    Chen, Meixia
    Liu, Hanmo
    Wu, Nan
    Hou, Jie
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [28] A Randomized, Double-Blind, Placebo-Controlled, Single-Centre, Single Ascending Dose And Multiple Ascending Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Molgramostim (rhgm-Csf) Administered By Inhalation To Healthy Adult Subjects
    Tarnow, I.
    Nymark, K.
    Vinge, M.
    Nielsen, K. A.
    Ganslandt, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [29] Results from the Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers
    Gurov, Xiaoshu Dai
    Merica, Elizabeth
    Iyer, Varsha
    Claeys, Annie
    Patil, Spurthi
    Urbstonaitis, Rolandas
    Xiao, James
    Callaghan, Michael U.
    BLOOD, 2022, 140 : 5426 - 5427
  • [30] SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF VIS649, AN APRIL-NEUTRALIZING IGG2 MONOCLONAL ANTIBODY, IN HEALTHY VOLUNTEERS: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE ASCENDING DOSE STUDY
    Suzuki, Yusuke
    Mathur, Mohit
    Barratt, Jonathan
    Engler, Frank
    Yarbrough, Jill
    Sloan, Susan
    Oldach, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
12345